Pfizer, Inc.

Regular divergence

265
Seems like we bottomed, because of the following facts.
We managed to pull back above the S1 Pivot point (with high volume).
Regular divergence occurred on the MACD indicator.
So the overall picture is bullish, but there is one catch; a lot depends on the overall market!
If the market continues to correct itself, then it might pull PFE down as well.
Be careful.

免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。